Shanghai Haohai Biological Technology Co. Ltd (5HB) — Cash Flow Reinvestment Rate
Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Cash Flow Reinvestment Rate of 1.04x as of June 2023, reinvesting €147.33 Million (capex €53.01 Million plus investments €-94.32 Million) from operating cash flow of €141.99 Million. See Shanghai Haohai Biological Technology Co (5HB) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Haohai Biological Technology Co. Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Shanghai Haohai Biological Technology Co. Ltd across 10 annual periods. For the full cash flow conversion analysis, see Shanghai Haohai Biological Technology Co cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Shanghai Haohai Biological Technology Co. Ltd (2016–2025)
Year-by-year capital reinvestment analysis for Shanghai Haohai Biological Technology Co. Ltd. See Shanghai Haohai Biological Technology Co financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.99x | €485.10 Million | €490.97 Million | €186.94 Million | ▼ -32.5% |
| 2024 | 1.46x | €949.62 Million | €648.57 Million | €363.49 Million | ▼ -0.6% |
| 2023 | 1.47x | €934.29 Million | €634.45 Million | €343.10 Million | ▼ -56.2% |
| 2022 | 3.36x | €777.76 Million | €231.30 Million | €309.21 Million | ▲ +255.7% |
| 2021 | 0.95x | €323.55 Million | €342.29 Million | €270.88 Million | ▼ -52.3% |
| 2020 | 1.98x | €519.25 Million | €262.07 Million | €189.70 Million | ▼ -26.2% |
| 2019 | 2.68x | €936.19 Million | €348.91 Million | €249.18 Million | ▲ +37.7% |
| 2018 | 1.95x | €762.61 Million | €391.28 Million | €151.21 Million | ▲ +53.2% |
| 2017 | 1.27x | €436.50 Million | €343.06 Million | €134.29 Million | ▼ -79.6% |
| 2016 | 6.24x | €1.59 Billion | €254.49 Million | €75.67 Million | — |